Media
News and press releases
Welcome to our media section. Check out the latest news and press releases from Cinclus Pharma and don’t hesitate to contact us if you need more information.
Latest pressreleases
Latest News
Read the full analysis of Cinclus Pharma in the article by Börsveckan.
Here you can read the full analysis of Cinclus Pharma in the article by Börsveckan.
Interview with CEO of Cinclus Pharma, Christer Ahlberg, after the listing.
Interview with CEO of Cinclus Pharma, Christer Ahlberg, after the listing.
Interview with Christer Ahlberg, CEO of Cinclus Pharma, in Börspodden
CEO of Cinclus Pharma, Christer Ahlberg, has participated in Börspodden to talk about the listing that took place last week and the upcoming plans for the company.
Highlights from today's IPO ceremony at Nasdaq Stockholm
Here are some highlights from today's IPO ceremony at Nasdaq Stockholm. Thanks to all of you who made this possible!
Cinclus Pharma in media
Christer Ahlberg, CEO of Cinclus Pharma participates in EFN Börslunch
2024-06-19[Swedish link] CEO of Cinclus Pharma, Christer Ahlberg, in EFN Börslunch at 10:45 June 19th.
Interview with Christer Ahlberg, CEO of Cinclus Pharma, in Trading Direkt
2024-06-18[Swedish link] Trading Direkt 2024-06-18 | IPO Cinclus Pharma
Christer Ahlberg, CEO of Cinclus Pharma, in an interview with Nordnet
2024-06-14Christer Ahlberg, CEO of Cinclus Pharma, talks about the company and the drug candidate linaprazan glurate in an interview with Nordnet.
Interview with Christer Ahlberg, CEO of Cinclus Pharma, in Penserpodden.
2024-06-14[Swedish link] Vi inleder avsnittet med Christer Ahlberg, VD för Cinclus Pharma, som med ett kompetent team i ryggen, en stark ägarbas och en mycket lovande läkemedelskandidat nu är börsaktuella.
Cinclus Pharma: IPO i rätt fas
2024-06-12[Swedish link] Läkemedelsutvecklingsbolaget Cinclus Pharma tar in drygt 700 Mkr för att finansiera fas-3-studier för en ny generations medicin mot svåra sura uppstötningar.
